Literature DB >> 9376187

The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft Tissue Tumours Working Group.

R L Haas1, R B Keus, B M Loftus, E J Rutgers, F van Coevorden, H Bartelink.   

Abstract

Dermatofibrosarcoma protuberans (DFSP), a fibrohistiocytic tumour of intermediate malignancy, has a strong tendency to recur locally. Wide local excision is the recommended treatment modality. A retrospective analysis was performed on 38 consecutive DFSP patients presenting to The Netherlands Cancer Institute, to define the role of radiotherapy. Of the 21 patients treated surgically (all with negative resection margins) seven recurred, a local control probability of 67%. Combined modality treatment was given to 17 patients. Prior to radiotherapy, these patients experienced 33 occurrences of DFSP, but after irradiation only three recurrences were seen, a local control probability of 82%. These results are in keeping with the recent literature where increasing value is being given to both adjuvant and curative radiotherapy in the local management of DFSP. We recommend radiotherapy in DFSP patients where repeated surgery may cause mutilation or functional impairment.

Entities:  

Mesh:

Year:  1997        PMID: 9376187     DOI: 10.1016/s0959-8049(97)00026-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  9 in total

1.  [Radiotherapy is effective in the adjuvant treatment of dermatofibroma protuberans].

Authors:  R Fietkau
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

2.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

Review 3.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

4.  [Dermatofibrosarcoma protuberans: report of 38 cases].

Authors:  Hanan El Kacemi; Abdellah Aissa; Amine Bazine; Tayeb Kebdani; Abdeslam Bougtab; Noureddine Benjaafar
Journal:  Pan Afr Med J       Date:  2014-11-12

Review 5.  The efficacy of Mohs micrographic surgery over the traditional wide local excision surgery in the cure of dermatofibrosarcoma protuberans.

Authors:  Malumani Malan; Wu Xuejingzi; Song Ji Quan
Journal:  Pan Afr Med J       Date:  2019-08-13

6.  Clinical features and prognostic factors of spinal fibroblastic/myofibroblastic tumors: a long-term, single-center, retrospective study.

Authors:  Haitao Sun; Shaohui He; Yuechao Zhao; Chen Ye; Xinghai Yang; Wei Xu; Jianru Xiao
Journal:  PeerJ       Date:  2020-12-16       Impact factor: 2.984

7.  Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib.

Authors:  Dennis A Wicherts; Frits van Coevorden; Houke M Klomp; Martine A van Huizum; J Martijn Kerst; Rick L M Haas; Hester H van Boven; J A van der Hage
Journal:  World J Surg Oncol       Date:  2013-03-08       Impact factor: 2.754

Review 8.  Dermatofibrosarcoma protuberans treated by micrographic surgery.

Authors:  A Ah-Weng; J R Marsden; D S A Sanders; R Waters
Journal:  Br J Cancer       Date:  2002-12-02       Impact factor: 7.640

Review 9.  Dermatofibrosarcoma protuberans: from translocation to targeted therapy.

Authors:  Jonathan Noujaim; Khin Thway; Cyril Fisher; Robin L Jones
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.